Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 2
2009 1
2010 1
2011 2
2012 9
2013 5
2014 4
2015 15
2016 19
2017 15
2018 18
2019 21
2020 23
2021 21
2022 27
2023 26
2024 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Results by year

Filters applied: . Clear all
Page 1
General Hepatitis.
Ellis K, Brandt-Sarif M, Sunny J, Koyfman S. Ellis K, et al. Among authors: koyfman s. Pediatr Rev. 2022 Sep 1;43(9):493-506. doi: 10.1542/pir.2021-005279. Pediatr Rev. 2022. PMID: 36045156 No abstract available.
Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society Appropriate Use Criteria.
Ward MC, Koyfman SA, Bakst RL, Margalit DN, Beadle BM, Beitler JJ, Chang SS, Cooper JS, Galloway TJ, Ridge JA, Robbins JR, Sacco AG, Tsai CJ, Yom SS, Siddiqui F. Ward MC, et al. Among authors: koyfman sa. Int J Radiat Oncol Biol Phys. 2022 Jul 15;113(4):759-786. doi: 10.1016/j.ijrobp.2022.03.034. Epub 2022 Apr 8. Int J Radiat Oncol Biol Phys. 2022. PMID: 35398456 Review.
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.
Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Jordan RCK, Zhao W, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT. Gillison ML, et al. Among authors: koyfman sa. Lancet. 2019 Jan 5;393(10166):40-50. doi: 10.1016/S0140-6736(18)32779-X. Epub 2018 Nov 15. Lancet. 2019. PMID: 30449625 Free PMC article. Clinical Trial.
Progressive Cranial Neuropathy.
Buchberger DS, Cook SK, Koyfman SA. Buchberger DS, et al. Among authors: koyfman sa. JAMA Neurol. 2023 Dec 1;80(12):1375-1376. doi: 10.1001/jamaneurol.2023.3706. JAMA Neurol. 2023. PMID: 37870852
2B Or Not 2B?
Koyfman SA. Koyfman SA. Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):8-9. doi: 10.1016/j.ijrobp.2023.07.013. Epub 2023 Aug 11. Int J Radiat Oncol Biol Phys. 2023. PMID: 37574247 No abstract available.
Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial.
Sherman EJ, Harris J, Bible KC, Xia P, Ghossein RA, Chung CH, Riaz N, Gunn GB, Foote RL, Yom SS, Wong SJ, Koyfman SA, Dzeda MF, Clump DA, Khan SA, Shah MH, Redmond K, Torres-Saavedra PA, Le QT, Lee NY. Sherman EJ, et al. Among authors: koyfman sa. Lancet Oncol. 2023 Feb;24(2):175-186. doi: 10.1016/S1470-2045(22)00763-X. Epub 2023 Jan 18. Lancet Oncol. 2023. PMID: 36681089 Free PMC article. Clinical Trial.
ACR Appropriateness criteria® for nasopharyngeal carcinoma.
Saba NF, Salama JK, Beitler JJ, Busse PM, Cooper JS, Jones CU, Koyfman S, Quon H, Ridge JA, Siddiqui F, Worden F, Yao M, Yom SS; Expert Panel on Radiation Oncology-Head and Neck Cancer. Saba NF, et al. Among authors: koyfman s. Head Neck. 2016 Jul;38(7):979-86. doi: 10.1002/hed.24423. Epub 2016 Apr 30. Head Neck. 2016. PMID: 27131050 Review.
186 results